Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART)
- 1 July 2001
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 7 (7) , 394-395
- https://doi.org/10.1046/j.1198-743x.2001.00270.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy.European Journal of Clinical Microbiology & Infectious Diseases, 2001
- Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individualsAIDS, 2000
- Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy.European Journal of Clinical Microbiology & Infectious Diseases, 2000
- Epidemiology of Human Immunodeficiency Virus–Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2000
- Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain.The American Journal of Tropical Medicine and Hygiene, 1998
- Leishmania and human immunodeficiency virus coinfection: the first 10 yearsClinical Microbiology Reviews, 1997